Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea

NCT ID: NCT01130272

Last Updated: 2019-10-22

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

807 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-04-28

Study Completion Date

2011-07-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the efficacy, safety, and tolerability of different doses of JNJ-27018966 (eluxadoline) compared with placebo in the treatment of patients with irritable bowel syndrome with diarrhea (IBS-d).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Irritable Bowel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Eluxadoline 5 mg

Eluxadoline 5 mg tablets, orally, twice daily for up to 12 weeks.

Group Type EXPERIMENTAL

Eluxadoline

Intervention Type DRUG

Tablets, orally, twice daily.

Eluxadoline 25 mg

Eluxadoline 25 mg tablets, orally, twice daily for up to 12 weeks. .

Group Type EXPERIMENTAL

Eluxadoline

Intervention Type DRUG

Tablets, orally, twice daily.

Eluxadoline 100 mg

Eluxadoline 100 mg tablets, orally, twice daily for up to 12 weeks.

Group Type EXPERIMENTAL

Eluxadoline

Intervention Type DRUG

Tablets, orally, twice daily.

Eluxadoline 200 mg

Eluxadoline 200 mg tablets, orally, twice daily for up to 12 weeks.

Group Type EXPERIMENTAL

Eluxadoline

Intervention Type DRUG

Tablets, orally, twice daily.

Placebo

Eluxadoline placebo matching tablets, orally, twice daily for up to 12 weeks.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Matching placebo oral tablets twice daily.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eluxadoline

Tablets, orally, twice daily.

Intervention Type DRUG

Placebo

Matching placebo oral tablets twice daily.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

JNJ-27018966

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient has a diagnosis of IBS by Rome III criteria with a subtype of diarrhea
* Female patients must be:
* postmenopausal, defined as amenorrhea for at least 2 years at Prescreening,
* surgically sterile (have had a hysterectomy or bilateral oophorectomy, tubal ligation, or otherwise be incapable of pregnancy),
* abstinent, or
* if sexually active, be practicing an effective method of birth control.

Exclusion Criteria

* Patient has a diagnosis of IBS by Rome III criteria with a subtype of constipation, mixed IBS, or unsubtyped IBS
* Patient has a history of inflammatory or immune-mediated gastrointestinal (GI) disorders including inflammatory bowel disease (ie, Crohn's disease, ulcerative colitis) and celiac disease
* Patient has a history of diverticulitis within 6 months prior to Prescreening
* Patient has a history of intestinal obstruction, stricture, toxic megacolon, GI perforation, fecal impaction, gastric banding, bariatric surgery, adhesions, ischemic colitis, impaired intestinal circulation (eg, aortoiliac disease), thrombophlebitis of a major vein, or hypercoagulable states.

Other protocol-specific eligibility criteria may apply.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Furiex Pharmaceuticals, Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Furiex Research Site

Anniston, Alabama, United States

Site Status

Furiex Research Site

Birmingham, Alabama, United States

Site Status

Furiex Research Site

Birmingham, Alabama, United States

Site Status

Furiex Research Site

Dothan, Alabama, United States

Site Status

Furiex Research Site

Huntsville, Alabama, United States

Site Status

Furiex Research Site

Huntsville, Alabama, United States

Site Status

Furiex Research Site

Mobile, Alabama, United States

Site Status

Furiex Research Site

Montgomery, Alabama, United States

Site Status

Furiex Research Site

Pell City, Alabama, United States

Site Status

Furiex Research Site

Chandler, Arizona, United States

Site Status

Furiex Research Site

Glendale, Arizona, United States

Site Status

Furiex Research Site

Mesa, Arizona, United States

Site Status

Furiex Research Site

Phoenix, Arizona, United States

Site Status

Furiex Research Site

Phoenix, Arizona, United States

Site Status

Furiex Research Site

Phoenix, Arizona, United States

Site Status

Furiex Research Site

Tempe, Arizona, United States

Site Status

Furiex Research Site

Tempe, Arizona, United States

Site Status

Furiex Research Site

Tucson, Arizona, United States

Site Status

Furiex Research Site

Tucson, Arizona, United States

Site Status

Furiex Research Site

Jonesboro, Arkansas, United States

Site Status

Furiex Research Site

Little Rock, Arkansas, United States

Site Status

Furiex Research Site

Searcy, Arkansas, United States

Site Status

Furiex Research Site

Sherwood, Arkansas, United States

Site Status

Furiex Research Site

Aliso Viejo, California, United States

Site Status

Furiex Research Site

Anaheim, California, United States

Site Status

Furiex Research Site

Azusa, California, United States

Site Status

Furiex Research Site

Burbank, California, United States

Site Status

Furiex Research Site

Carlsbad, California, United States

Site Status

Furiex Research Site

Encinitas, California, United States

Site Status

Furiex Research Site

Garden Grove, California, United States

Site Status

Furiex Research Site

Garden Grove, California, United States

Site Status

Furiex Research Site

Inglewood, California, United States

Site Status

Furiex Research Site

Laguna Hills, California, United States

Site Status

Furiex Research Site

Long Beach, California, United States

Site Status

Furiex Research Site

Los Angeles, California, United States

Site Status

Furiex Research Site

Los Angeles, California, United States

Site Status

Furiex Research Site

Murrieta, California, United States

Site Status

Furiex Research Site

Oakland, California, United States

Site Status

Furiex Research Site

Orange, California, United States

Site Status

Furiex Research Site

Sacramento, California, United States

Site Status

Furiex Research Site

San Carlos, California, United States

Site Status

Furiex Research Site

San Diego, California, United States

Site Status

Furiex Research Site

San Diego, California, United States

Site Status

Furiex Research Site

Colorado Springs, Colorado, United States

Site Status

Furiex Research Site

Colorado Springs, Colorado, United States

Site Status

Furiex Research Site

Colorado Springs, Colorado, United States

Site Status

Furiex Research Site

Colorado Springs, Colorado, United States

Site Status

Furiex Research Site

Denver, Colorado, United States

Site Status

Furiex Research Site

Denver, Colorado, United States

Site Status

Furiex Research Site

Lakewood, Colorado, United States

Site Status

Furiex Research Site

Littleton, Colorado, United States

Site Status

Furiex Research Site

Thornton, Colorado, United States

Site Status

Furiex Research Site

Bristol, Connecticut, United States

Site Status

Furiex Research Site

Waterbury, Connecticut, United States

Site Status

Furiex Research Site

Aventura, Florida, United States

Site Status

Furiex Research Site

Boca Raton, Florida, United States

Site Status

Furiex Research Site

Boca Raton, Florida, United States

Site Status

Furiex Research Site

Bradenton, Florida, United States

Site Status

Furiex Research Site

Brandon, Florida, United States

Site Status

Furiex Research Site

Chipley, Florida, United States

Site Status

Furiex Research Site

DeLand, Florida, United States

Site Status

Furiex Research Site

Delray Beach, Florida, United States

Site Status

Furiex Research Site

Doral, Florida, United States

Site Status

Furiex Research Site

Fort Lauderdale, Florida, United States

Site Status

Furiex Research Site

Hialeah, Florida, United States

Site Status

Furiex Research Site

Hialeah, Florida, United States

Site Status

Furiex Research Site

Inverness, Florida, United States

Site Status

Furiex Research Site

Jacksonville, Florida, United States

Site Status

Furiex Research Site

Jacksonville, Florida, United States

Site Status

Furiex Research Site

Jupiter, Florida, United States

Site Status

Furiex Research Site

Kissimmee, Florida, United States

Site Status

Furiex Research Site

Largo, Florida, United States

Site Status

Furiex Research Site

Lauderdale Lakes, Florida, United States

Site Status

Furiex Research Site

Melbourne, Florida, United States

Site Status

Furiex Research Site

Miami, Florida, United States

Site Status

Furiex Research Site

Miami, Florida, United States

Site Status

Furiex Research Site

Miami, Florida, United States

Site Status

Furiex Research Site

Naples, Florida, United States

Site Status

Furiex Research Site

Naples, Florida, United States

Site Status

Furiex Research Site

New Port Richey, Florida, United States

Site Status

Furiex Research Site

New Port Richey, Florida, United States

Site Status

Furiex Research Site

New Smyrna Beach, Florida, United States

Site Status

Furiex Research Site

Orlando, Florida, United States

Site Status

Furiex Research Site

Plantation, Florida, United States

Site Status

Furiex Research Site

Port Orange, Florida, United States

Site Status

Furiex Research Site

South Miami, Florida, United States

Site Status

Furiex Research Site

St. Petersburg, Florida, United States

Site Status

Furiex Research Site

Tampa, Florida, United States

Site Status

Furiex Research Site

Tampa, Florida, United States

Site Status

Furiex Research Site

Atlanta, Georgia, United States

Site Status

Furiex Research Site

Atlanta, Georgia, United States

Site Status

Furiex Research Site

Columbus, Georgia, United States

Site Status

Furiex Research Site

Duluth, Georgia, United States

Site Status

Furiex Research Site

Macon, Georgia, United States

Site Status

Furiex Research Site

Marietta, Georgia, United States

Site Status

Furiex Research Site

Newnan, Georgia, United States

Site Status

Furiex Research Site

Rome, Georgia, United States

Site Status

Furiex Research Site

Sandy Springs, Georgia, United States

Site Status

Furiex Research Site

Savannah, Georgia, United States

Site Status

Furiex Research Site

Boise, Idaho, United States

Site Status

Furiex Research Site

Boise, Idaho, United States

Site Status

Furiex Research Site

Idaho Falls, Idaho, United States

Site Status

Furiex Research Site

Meridian, Idaho, United States

Site Status

Furiex Research Site

Nampa, Idaho, United States

Site Status

Furiex Research Site

Champaign, Illinois, United States

Site Status

Furiex Research Site

Chicago, Illinois, United States

Site Status

Furiex Research Site

Morton, Illinois, United States

Site Status

Furiex Research Site

Anderson, Indiana, United States

Site Status

Furiex Research Site

Bloomington, Indiana, United States

Site Status

Furiex Research Site

Evansville, Indiana, United States

Site Status

Furiex Research Site

Indianapolis, Indiana, United States

Site Status

Furiex Research Site

Indianapolis, Indiana, United States

Site Status

Furiex Research Site

Indianapolis, Indiana, United States

Site Status

Furiex Research Site

Lenexa, Kansas, United States

Site Status

Furiex Research Site

Mission, Kansas, United States

Site Status

Furiex Research Site

Overland Park, Kansas, United States

Site Status

Furiex Research Site

Overland Park, Kansas, United States

Site Status

Furiex Research Site

Topeka, Kansas, United States

Site Status

Furiex Research Site

Wichita, Kansas, United States

Site Status

Furiex Research Site

Bowling Green, Kentucky, United States

Site Status

Furiex Research Site

Lexington, Kentucky, United States

Site Status

Furiex Research Site

Louisville, Kentucky, United States

Site Status

Furiex Research Site

Metairie, Louisiana, United States

Site Status

Furiex Research Site

Monroe, Louisiana, United States

Site Status

Furiex Research Site

Opelousas, Louisiana, United States

Site Status

Furiex Research Site

Shreveport, Louisiana, United States

Site Status

Furiex Research Site

Shreveport, Louisiana, United States

Site Status

Furiex Research Site

Annapolis, Maryland, United States

Site Status

Furiex Research Site

Chevy Chase, Maryland, United States

Site Status

Furiex Research Site

Hollywood, Maryland, United States

Site Status

Furiex Research Site

Laurel, Maryland, United States

Site Status

Furiex Research Site

Lutherville, Maryland, United States

Site Status

Furiex Research Site

Prince Frederick, Maryland, United States

Site Status

Furiex Research Site

Rockville, Maryland, United States

Site Status

Furiex Research Site

Boston, Massachusetts, United States

Site Status

Furiex Research Site

Boston, Massachusetts, United States

Site Status

Furiex Research Site

Boston, Massachusetts, United States

Site Status

Furiex Research Site

Brockton, Massachusetts, United States

Site Status

Furiex Research Site

Hyannis, Massachusetts, United States

Site Status

Furiex Research Site

Springfield, Massachusetts, United States

Site Status

Furiex Research Site

Chesterfield, Michigan, United States

Site Status

Furiex Research Site

Interlochen, Michigan, United States

Site Status

Furiex Research Site

Kalamazoo, Michigan, United States

Site Status

Furiex Research Site

Novi, Michigan, United States

Site Status

Furiex Research Site

Troy, Michigan, United States

Site Status

Furiex Research Site

Chaska, Minnesota, United States

Site Status

Furiex Research Site

Jackson, Mississippi, United States

Site Status

Furiex Research Site

Tupelo, Mississippi, United States

Site Status

Furiex Research Site

City of Saint Peters, Missouri, United States

Site Status

Furiex Research Site

Mexico, Missouri, United States

Site Status

Furiex Research Site

St Louis, Missouri, United States

Site Status

Furiex Research Site

Billings, Montana, United States

Site Status

Furiex Research Site

Bozeman, Montana, United States

Site Status

Furiex Research Site

Bellevue, Nebraska, United States

Site Status

Furiex Research Site

Omaha, Nebraska, United States

Site Status

Furiex Research Site

Omaha, Nebraska, United States

Site Status

Furiex Research Site

Henderson, Nevada, United States

Site Status

Furiex Research Site

Las Vegas, Nevada, United States

Site Status

Furiex Research Site

Las Vegas, Nevada, United States

Site Status

Furiex Research Site

Atco, New Jersey, United States

Site Status

Furiex Research Site

Blackwood, New Jersey, United States

Site Status

Furiex Research Site

Elizabeth, New Jersey, United States

Site Status

Furiex Research Site

Marlton, New Jersey, United States

Site Status

Furiex Research Site

Morristown, New Jersey, United States

Site Status

Furiex Research Site

South Bound Brook, New Jersey, United States

Site Status

Furiex Research Site

Vineland, New Jersey, United States

Site Status

Furiex Research Site

Albuquerque, New Mexico, United States

Site Status

Furiex Research Site

Albuquerque, New Mexico, United States

Site Status

Furiex Research Site

Binghamton, New York, United States

Site Status

Furiex Research Site

Brooklyn, New York, United States

Site Status

Furiex Research Site

Brooklyn, New York, United States

Site Status

Furiex Research Site

Great Neck, New York, United States

Site Status

Furiex Research Site

Great Neck, New York, United States

Site Status

Furiex Research Site

Mineola, New York, United States

Site Status

Furiex Research Site

New York, New York, United States

Site Status

Furiex Research Site

Boone, North Carolina, United States

Site Status

Furiex Research Site

Chapel Hill, North Carolina, United States

Site Status

Furiex Research Site

Charlotte, North Carolina, United States

Site Status

Furiex Research Site

Charlotte, North Carolina, United States

Site Status

Furiex Research Site

Fayetteville, North Carolina, United States

Site Status

Furiex Research Site

Greensboro, North Carolina, United States

Site Status

Furiex Research Site

Greensboro, North Carolina, United States

Site Status

Furiex Research Site

Greenville, North Carolina, United States

Site Status

Furiex Research Site

Harrisburg, North Carolina, United States

Site Status

Furiex Research Site

Hickory, North Carolina, United States

Site Status

Furiex Research Site

Hickory, North Carolina, United States

Site Status

Furiex Research Site

High Point, North Carolina, United States

Site Status

Furiex Research Site

Jacksonville, North Carolina, United States

Site Status

Furiex Research Site

New Bern, North Carolina, United States

Site Status

Furiex Research Site

Raleigh, North Carolina, United States

Site Status

Furiex Research Site

Raleigh, North Carolina, United States

Site Status

Furiex Research Site

Wilmington, North Carolina, United States

Site Status

Furiex Research Site

Winston-Salem, North Carolina, United States

Site Status

Furiex Research Site

Winston-Salem, North Carolina, United States

Site Status

Furiex Research Site

Fargo, North Dakota, United States

Site Status

Furiex Research Site

Fargo, North Dakota, United States

Site Status

Furiex Research Site

Akron, Ohio, United States

Site Status

Furiex Research Site

Beachwood, Ohio, United States

Site Status

Furiex Research Site

Beavercreek, Ohio, United States

Site Status

Furiex Research Site

Cincinnati, Ohio, United States

Site Status

Furiex Research Site

Cleveland, Ohio, United States

Site Status

Furiex Research Site

Columbus, Ohio, United States

Site Status

Furiex Research Site

Columbus, Ohio, United States

Site Status

Furiex Research Site

Dayton, Ohio, United States

Site Status

Furiex Research Site

Franklin, Ohio, United States

Site Status

Furiex Research Site

Mentor, Ohio, United States

Site Status

Furiex Research Site

Miamisburg, Ohio, United States

Site Status

Furiex Research Site

Springfield, Ohio, United States

Site Status

Furiex Research Site

Wadsworth, Ohio, United States

Site Status

Furiex Research Site

Norman, Oklahoma, United States

Site Status

Furiex Research Site

Norman, Oklahoma, United States

Site Status

Furiex Research Site

Oklahoma City, Oklahoma, United States

Site Status

Furiex Research Site

Oklahoma City, Oklahoma, United States

Site Status

Furiex Research Site

Yukon, Oklahoma, United States

Site Status

Furiex Research Site

Dingmans Ferry, Pennsylvania, United States

Site Status

Furiex Research Site

Hermitage, Pennsylvania, United States

Site Status

Furiex Research Site

Jenkintown, Pennsylvania, United States

Site Status

Furiex Research Site

Lancaster, Pennsylvania, United States

Site Status

Furiex Research Site

Lansdale, Pennsylvania, United States

Site Status

Furiex Research Site

Newton, Pennsylvania, United States

Site Status

Furiex Research Site

Sayre, Pennsylvania, United States

Site Status

Furiex Research Site

Uniontown, Pennsylvania, United States

Site Status

Furiex Research Site

Washington, Pennsylvania, United States

Site Status

Furiex Research Site

Cumberland, Rhode Island, United States

Site Status

Furiex Research Site

East Providence, Rhode Island, United States

Site Status

Furiex Research Site

Warwick, Rhode Island, United States

Site Status

Furiex Research Site

Anderson, South Carolina, United States

Site Status

Furiex Research Site

Columbia, South Carolina, United States

Site Status

Furiex Research Site

Columbia, South Carolina, United States

Site Status

Furiex Research Site

Greer, South Carolina, United States

Site Status

Furiex Research Site

Mt. Pleasant, South Carolina, United States

Site Status

Furiex Research Site

Rapid City, South Dakota, United States

Site Status

Furiex Research Site

Bristol, Tennessee, United States

Site Status

Furiex Research Site

Chattanooga, Tennessee, United States

Site Status

Furiex Research Site

Chattanooga, Tennessee, United States

Site Status

Furiex Research Site

Germantown, Tennessee, United States

Site Status

Furiex Research Site

Jackson, Tennessee, United States

Site Status

Furiex Research Site

Johnson City, Tennessee, United States

Site Status

Furiex Research Site

Kingsport, Tennessee, United States

Site Status

Furiex Research Site

Nashville, Tennessee, United States

Site Status

Furiex Research Site

Nashville, Tennessee, United States

Site Status

Furiex Research Site

Austin, Texas, United States

Site Status

Furiex Research Site

Bedford, Texas, United States

Site Status

Furiex Research Site

Colleyville, Texas, United States

Site Status

Furiex Research Site

El Paso, Texas, United States

Site Status

Furiex Research Site

Fort Worth, Texas, United States

Site Status

Furiex Research Site

Fort Worth, Texas, United States

Site Status

Furiex Research Site

Grand Prairie, Texas, United States

Site Status

Furiex Research Site

Grapevine, Texas, United States

Site Status

Furiex Research Site

Houston, Texas, United States

Site Status

Furiex Research Site

Houston, Texas, United States

Site Status

Furiex Research Site

Houston, Texas, United States

Site Status

Furiex Research Site

Houston, Texas, United States

Site Status

Furiex Research Site

Houston, Texas, United States

Site Status

Furiex Research Site

Houston, Texas, United States

Site Status

Furiex Research Site

Houston, Texas, United States

Site Status

Furiex Research Site

Houston, Texas, United States

Site Status

Furiex Research Site

Hurst, Texas, United States

Site Status

Furiex Research Site

Irving, Texas, United States

Site Status

Furiex Research Site

Lake Jackson, Texas, United States

Site Status

Furiex Research Site

Marshall, Texas, United States

Site Status

Furiex Research Site

North Richland Hills, Texas, United States

Site Status

Furiex Research Site

Odessa, Texas, United States

Site Status

Furiex Research Site

Plano, Texas, United States

Site Status

Furiex Research Site

San Antonio, Texas, United States

Site Status

Furiex Research Site

San Antonio, Texas, United States

Site Status

Furiex Research Site

San Antonio, Texas, United States

Site Status

Furiex Research Site

San Antonio, Texas, United States

Site Status

Furiex Research Site

San Antonio, Texas, United States

Site Status

Furiex Research Site

Sugar Land, Texas, United States

Site Status

Furiex Research Site

Sugar Land, Texas, United States

Site Status

Furiex Research Site

Webster, Texas, United States

Site Status

Furiex Research Site

Logan, Utah, United States

Site Status

Furiex Research Site

Ogden, Utah, United States

Site Status

Furiex Research Site

Salt Lake City, Utah, United States

Site Status

Furiex Research Site

Salt Lake City, Utah, United States

Site Status

Furiex Research Site

South Jordan, Utah, United States

Site Status

Furiex Research Site

West Jordan, Utah, United States

Site Status

Furiex Research Site

West Valley City, Utah, United States

Site Status

Furiex Research Site

Alexandria, Virginia, United States

Site Status

Furiex Research Site

Chesapeake, Virginia, United States

Site Status

Furiex Research Site

Christiansburg, Virginia, United States

Site Status

Furiex Research Site

Danville, Virginia, United States

Site Status

Furiex Research Site

Fairfax, Virginia, United States

Site Status

Furiex Research Site

Virginia Beach, Virginia, United States

Site Status

Furiex Research Site

Mill Creek, Washington, United States

Site Status

Furiex Research Site

Madison, Wisconsin, United States

Site Status

Furiex Research Site

Milwaukee, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Fant RV, Henningfield JE, Cash BD, Dove LS, Covington PS. Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea. Clin Gastroenterol Hepatol. 2017 Jul;15(7):1021-1029.e6. doi: 10.1016/j.cgh.2017.01.026. Epub 2017 Feb 3.

Reference Type DERIVED
PMID: 28167156 (View on PubMed)

Andrae DA, Covington PS, Patrick DL. Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome. Clin Ther. 2014 May;36(5):663-79. doi: 10.1016/j.clinthera.2014.04.009. Epub 2014 May 9.

Reference Type DERIVED
PMID: 24813429 (View on PubMed)

Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study. Gastroenterology. 2013 Aug;145(2):329-38.e1. doi: 10.1053/j.gastro.2013.04.006. Epub 2013 Apr 9.

Reference Type DERIVED
PMID: 23583433 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

27018966IBS2001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.